Format

Send to

Choose Destination
J Chemother. 2004 Apr;16(2):119-21.

In-vitro activity of nisin against clinical isolates of Clostridium difficile.

Author information

1
Clinica Malattie Infettive, Università di Firenze, Ospedale di Careggi, Viale Morgagni 85, I-50134 Florence, Italy. bartolonia@ao-careggi.toscana.it

Abstract

Nisin is a cationic peptide produced by Lactococcus lactis. Its activity against clinical isolates of Clostridium difficile was compared to that of vancomycin and metronidazole by minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and time-kill studies. Nisin was more active than the other agents, with a MIC90 of 0.256 mg/L and strong bactericidal activity. Nisin may be a promising agent for the management of C. difficile associated diarrhea.

PMID:
15216943
DOI:
10.1179/joc.2004.16.2.119
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center